H44.023 Vitreous abscess (chronic), bilateral

Name of the Condition

• Vitreous abscess (chronic), bilateral

Summary

Vitreous abscess (chronic), bilateral is a persistent intraocular infection characterized by the accumulation of pus within the vitreous humor of both eyes. It is a sight-threatening condition that requires ongoing medical management to prevent permanent vision loss. The chronic nature indicates a prolonged or recurrent infection, often with slower progression compared to acute forms. The bilateral specification denotes involvement of both eyes.

Causes

The condition is typically caused by bacterial or fungal infections that persist within the vitreous of both eyes. These infections may originate from penetrating eye trauma, surgery, or spread from adjacent ocular structures. Chronic infections may develop if acute infections are inadequately treated or if the immune response is insufficient to clear the pathogen. The chronic designation suggests the infection has persisted over time, leading to ongoing inflammation and abscess formation.

Risk Factors

• Previous eye surgery or trauma with delayed healing affecting both eyes.
• Immunocompromised states (e.g., diabetes, HIV, or immunosuppressive therapy).
• Pre-existing ocular infections or inflammation in both eyes that were not fully resolved.
• Use of intraocular devices or implants in both eyes that may harbor bacteria.
• Systemic infections that spread to both eyes over an extended period.

Symptoms

• Gradual or persistent decrease in vision in both eyes.
• Eye pain or discomfort.
• Redness or inflammation of the eyes.
• Floaters or spots in the visual field.
• Sensitivity to light.
• Possible discharge or pus visible in the eyes.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, slit-lamp examination, and dilated fundus evaluation. Imaging studies such as ultrasound or optical coherence tomography (OCT) may be used to assess the vitreous and detect abscess formation. Laboratory tests, including cultures of ocular fluids or samples, help identify the causative organism. The bilateral nature of the condition is confirmed through examination of both eyes.

Treatment Options

Treatment typically includes long-term antimicrobial therapy (antibiotics or antifungals) tailored to the identified pathogen. Intravitreal injections or systemic medications may be administered. Surgical intervention, such as vitrectomy, may be necessary to remove the abscess and infected vitreous. Adjunctive therapies, like corticosteroids, may be used to reduce inflammation. Close monitoring and follow-up are essential to adjust treatment as needed.

Prognosis and Follow-Up

Prognosis depends on the severity of the infection, timeliness of treatment, and response to therapy. Chronic bilateral involvement increases the risk of permanent vision loss if not managed effectively. Regular follow-up appointments are critical to monitor visual function, assess treatment response, and detect complications early. Long-term management may be required to prevent recurrence.

Complications

• Permanent vision loss or blindness.
• Retinal detachment.
• Cataract formation.
• Glaucoma.
• Spread of infection to other ocular structures or systemic involvement.
• Chronic inflammation leading to scarring.

Lifestyle & Prevention

• Maintain good eye hygiene and avoid trauma to the eyes.
• Manage underlying conditions like diabetes or immunocompromised states.
• Follow post-surgical or post-trauma care instructions carefully.
• Seek prompt treatment for any ocular infections or injuries.
• Avoid sharing eye makeup or contact lenses to reduce infection risk.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden or worsening vision loss, severe eye pain, increased redness, or discharge. Early intervention is crucial to prevent permanent damage, especially in bilateral cases. Do not delay care if symptoms persist or worsen over time.

Tips for Medical Coders

Document the bilateral nature of the vitreous abscess and the chronic designation clearly in the medical record. Ensure the code H44.023 is used only when both eyes are affected and the condition is chronic. Include details about the causative organism, treatment, and any associated complications to support accurate coding and billing. Verify that the diagnosis aligns with clinical findings and documentation standards.